Organon (OGN) Change in Accured Expenses (2020 - 2026)

Organon (OGN) has reported Change in Accured Expenses for 7 consecutive years, with $95.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 143.59% year-over-year to $95.0 million; the TTM figure through Mar 2026 stood at -$86.0 million (down 82.98% YoY), while the FY2025 annual figure was -$142.0 million, down 40.59% from the prior year.
• Change in Accured Expenses came in at $95.0 million for Q1 2026 at Organon, up from -$156.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $165.0 million in Q3 2023, with the low at -$156.0 million in Q4 2025.
• Average Change in Accured Expenses over 5 years is $7.4 million, with a median of -$8.0 million recorded in 2022.
• Across the five-year window, Change in Accured Expenses sank 950.0% in 2023 and surged 360.0% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $64.0 million in 2022, then rose by 6.25% to $68.0 million in 2023, then slumped by 207.35% to -$73.0 million in 2024, then plunged by 113.7% to -$156.0 million in 2025, then soared by 160.9% to $95.0 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $95.0 million, -$156.0 million, and $73.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.